Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467 · see citing works

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works

Beyond Cholesterol

Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425 · see citing works

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Hámberg, M., Svensson, J., & Samuelsson, B. O. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,064 · see citing works

Role of oxidized low density lipoprotein in atherogenesis.

Witztum, J. L., & Steinberg, D. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,682 · see citing works

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148 · see citing works

Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2

Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973 · see citing works

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898 · see citing works

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

Tuomilehto, J., Vidgrén, G., Toivanen, L., Tuomilehto‐Wolf, E., Kohtamäki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M. J., & Koskela, P. U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,691 · see citing works

The role of oxidized lipoproteins in atherogenesis

Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,365 · see citing works

Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage

Morrow, J. D., Frei, B. B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,340 · see citing works

The measurement and mechanism of lipid peroxidation in biological systems

Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,292 · see citing works

Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease

Brown, B., Zhao, X., Sacco, D., & Albers, J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 886 · see citing works

The Yin and Yang of Oxidation in the Development of the Fatty Streak

Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M., Lusis, A. J., Shih, D. M., Lenten, B. J. V., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 699 · see citing works

Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone.

Bolli, R., Patel, B. S., Jeroudi, M. O., Lai, E. K., & McCay, P. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113621 · Cited by 685 · see citing works

Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers

Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612 · see citing works

Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.

Bolli, R., Jeroudi, M. O., Patel, B. S., Aruoma, O. I., Halliwell, B. B., Lai, E. K., & McCay, P. B. (1989) · Circulation Research · doi:10.1161/01.res.65.3.607 · Cited by 579 · see citing works

Myocardial 'stunning' in man.

Bolli, R. (1992) · Circulation · doi:10.1161/01.cir.86.6.1671 · Cited by 529 · see citing works

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

Takahashi, K., Nammour, T., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 510 · see citing works

Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.

Kloner, R. A., Przyklenk, K., & Whittaker, P. (1989) · Circulation · doi:10.1161/01.cir.80.5.1115 · Cited by 504 · see citing works

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.

FitzGerald, G. A., Pedersen, A. K., & Patrono, C. (1983) · Circulation · doi:10.1161/01.cir.67.6.1174 · Cited by 472 · see citing works

The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data

Jha, P., Flather, M., Lonn, E., Farkouh, M., & Yusuf, S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00009 · Cited by 399 · see citing works

Plasma 8‐epi‐PGF_2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., & Nourooz-Zadeh, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00649-t · Cited by 390 · see citing works

Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L. G., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344 · see citing works

Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.

Wang, Z., Ciabattoni, G., Créminon, C., Lawson, J. A., FitzGerald, G. A., Patrono, C., & Maclouf, J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12087-9 · Cited by 341 · see citing works

Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery

Breisblatt, W. M., Stein, K. L., Wolfe, C. J., Follansbee, W. P., Capozzi, J., Armitage, J. M., & Hardesty, R. L. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80011-7 · Cited by 316 · see citing works

α-Tocopherol Inhibits Aggregation of Human Platelets by a Protein Kinase C–Dependent Mechanism

Freedman, J. E., Farhat, J. H., Loscalzo, J., & Keaney, J. F. (1996) · Circulation · doi:10.1161/01.cir.94.10.2434 · Cited by 311 · see citing works

Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.

Morrow, J. D., Minton, T. A., Mukundan, C. R., Campbell, M., Zackert, W. E., Daniel, V. C., Badr, K. F., Blair, I. A., & Roberts, L. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41781-9 · Cited by 299 · see citing works

Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM

Tsai, E. C., Hirsch, I. B., Brunzell, J. D., & Chait, A. (1994) · Diabetes · doi:10.2337/diab.43.8.1010 · Cited by 281 · see citing works

8-Epi PGF2αGeneration During Coronary Reperfusion

Delanty, N., Reilly, M. P., Praticò, D., Lawson, J. A., McCarthy, J. F., Wood, A., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267 · see citing works

Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α

Praticò, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 266 · see citing works

Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells

Fukunaga, M., Makita, N., Roberts, L. J., Morrow, J. D., Takahashi, K., & Badr, K. F. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1619 · Cited by 254 · see citing works

Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.

Lynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236 · see citing works

The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist

Morrow, J. D., Minton, T. A., & Roberts, L. J. (1992) · Prostaglandins · doi:10.1016/0090-6980(92)90077-7 · Cited by 215 · see citing works

Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs

Gross, G. J., Farber, N. E., Hardman, H. F., & Warltier, D. C. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.3.h372 · Cited by 206 · see citing works

Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor Isoforms

Praticò, D., Smyth, E. M., Violi, F., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14916 · Cited by 204 · see citing works

Generation of 8-Epiprostaglandin F by Human Monocytes

Praticò, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 188 · see citing works

Increased thromboxane biosynthesis in type IIa hypercholesterolemia.

Davı̀, G., Averna, M. R., Catalano, I., Barbagallo, C. M., Ganci, A., Notarbartolo, A., Ciabattoni, G., & Patrono, C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1792 · Cited by 166 · see citing works

Antioxidant Vitamins and Cardiovascular Disease

Buring, J. E., & Gaziano, J. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-6242-6_9 · Cited by 162 · see citing works

The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.

Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160 · see citing works

Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma.

Awad, J. A., Morrow, J. D., Takahashi, K., & Roberts, L. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53593-6 · Cited by 158 · see citing works

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients

Lavy, A., Brook, G. J., Dankner, G., Amotz, A. B., & Aviram, M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90005-h · Cited by 156 · see citing works

Identification of the Major Urinary Metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in Humans

Roberts, L. J., Moore, K. P., Zackert, W. E., Oates, J. A., & Morrow, J. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20617 · Cited by 154 · see citing works

Assay of Malondialdehyde in Biological Fluids by Gas Chromatography-Mass Spectrometry

Yeo, H.-R., Helbock, H. J., Chyu, D. W., & Ames, B. N. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1355 · Cited by 148 · see citing works

Stereochemical course of the autooxidative cyclization of lipid hydroperoxides to prostaglandin-like bicyclic endoperoxides

O'Connor, D. E., Mihelich, E. D., & Coleman, M. C. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00324a028 · Cited by 124 · see citing works

Functional Characterization of the Ocular Prostaglandin F2α (PGF2α) Receptor

Kunapuli, P., Lawson, J. A., Rokach, J., & FitzGerald, G. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27147 · Cited by 102 · see citing works

Isoleukotrienes are biologically active free radical products of lipid peroxidation

Harrison, K. A., & Murphy, R. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17273 · Cited by 98 · see citing works

Lipid peroxidation associated with successful thrombolysis

Ranjadayalan, K. (1990) · The Lancet · doi:10.1016/0140-6736(90)90866-4 · Cited by 96 · see citing works

Lipoprotein Oxidation and Lipoprotein-lnduced Cell Injury in Diabetes

Chisolm, G. M., Irwin, K. C., & Penn, M. S. (1992) · Diabetes · doi:10.2337/diab.41.2.s61 · Cited by 89 · see citing works

Evidence for episodic platelet activation in acute ischemic stroke.

van Kooten, F., Ciabattoni, G., Patrono, C., Schmitz, P. I. M., van Gijn, J., & Koudstaal, P. J. (1994) · Stroke · doi:10.1161/01.str.25.2.278 · Cited by 83 · see citing works

Effects of the novel anti‐inflammatory compounds, N‐[2‐(cyclohexyloxy)‐4‐nitrophenyl] methanesulphonamide (NS‐398) and 5‐methanesulphonamido‐6‐(2, 4‐difluorothiophenyl)‐1‐indanone (L‐745, 337), on the cyclo‐oxygenase activity of human blood prostaglandin endoperoxide synthases

Panara, M. R., Greco, A., Santini, G., Sciulli, M. G., Rotondo, M. T., Padovano, R., di Giamberardino, M., Cipollone, F., Cuccurullo, F., Patrono, C., et al. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15091.x · Cited by 82 · see citing works

Assessment of myocardial oxidative stress in patients after myocardial revascularization

Ferreira, R., Llesuy, S., Milei, J., Scordo, D., Hourquebie, H., Molteni, L., de Palma, C., & Boveris, A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90475-9 · Cited by 80 · see citing works

Induction of prostaglandin endoperoxide synthase‐2 in human monocytes associated with cyclo‐oxygenase‐dependent F2‐isoprostane formation

Patrignani, P., Santini, G., Panara, M. R., Sciulli, M. G., Greco, A., Rotondo, M. T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., & Patrono, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15535.x · Cited by 75 · see citing works

Human globin gene analysis for a patient with beta-o/delta beta-thalassemia.

Ottolenghi, S., Lanyon, W. G., Williamson, R., Weatherall, D. J., Clegg, J. B., & Pitcher, C. S. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.6.2294 · Cited by 69 · see citing works

Cyclooxygenase‐Dependent Formation of the Isoprostane 8‐EPI Prostaglandin F2αa

Praticò, D., Lawson, J. A., & FitzGerald, G. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb52730.x · Cited by 66 · see citing works

Total synthesis of a novel isoprostane IPF2α-I and its identification in biological fluids

Adiyaman, M., Lawson, J. A., Hwang, S., Khanapure, S. P., FitzGerald, G. A., & Rokach, J. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)00973-2 · Cited by 55 · see citing works

Is Pentane a Normal Constituent of Human Breath?

Cailleux, A., & Allain, P. (1993) · Free Radical Research Communications · doi:10.3109/10715769309147499 · Cited by 47 · see citing works

Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors

Patrono, C., Davı̀, G., & Ciabattoni, G. (1992) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(92)90039-u · Cited by 36 · see citing works

The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.

Cominacini, L., Pastorino, A. M., Garbin, U., Campagnola, M., de Santis, A., Davoli, A., Faccini, G., Bertozzo, L., Pasini, F., & Af, P. (1994) · PubMed · Cited by 27 · see citing works

Free radical activity and left ventricular function after thrombolysis for acute infarction.

Davies, S., Ranjadayalan, K., Wickens, D. G., Dormandy, T. L., Umachandran, V., & Timmis, A. (1993) · Heart · doi:10.1136/hrt.69.2.114 · Cited by 21 · see citing works

Coronary heart disease and vitamin E

Riemersma, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90861-2 · Cited by 17 · see citing works

Role of Oxidative Modifications in Atherosclerosis

Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,611 · see citing works

Oxidative stress and metabolic syndrome

Roberts, C. K., & Sindhu, K. K. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.02.026 · Cited by 865 · see citing works

Isoprostanes: markers and mediators of oxidative stress

Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747 · see citing works

In Vivo Formation of 8-Iso-Prostaglandin F_2αand Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation

Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742 · see citing works

Endothelial function and dysfunction. Part I

Deanfield, J. E., Donald, A. E., Ferri, C., Giannattasio, C., Halcox, J., Halligan, S., Lerman, A., Mancia, G., Oliver, J. J., Pessina, A. C., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00004 · Cited by 634 · see citing works

VITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION

Singh, U. P., Devaraj, S., & Jialal, I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132446 · Cited by 574 · see citing works

Effects of exercise and diet on chronic disease

Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556 · see citing works

Platelet Activation in Obese Women

Davı̀, G., Guagnano, M. T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S., & Patrono, C. (2002) · JAMA · doi:10.1001/jama.288.16.2008 · Cited by 542 · see citing works

The Role of Oxidative Stress in Diabetic Complications

Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 528 · see citing works

Platelet activation in type 2 diabetes mellitus

Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493 · see citing works

Human health implications of environmental contaminants in Arctic Canada: a review

Oostdam, J. V., Gilman, A. P., Dewailly, É., Usher, P. J., Wheatley, B., Kuhnlein, H. V., Neve, S. D., Walker, J. B., Tracy, B. L., Feeley, M., et al. (1999) · The Science of The Total Environment · doi:10.1016/s0048-9697(99)00036-4 · Cited by 498 · see citing works

Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501 · see citing works

Oxidative stress and atherosclerosis

Singh, U. S., & Jialal, I. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.002 · Cited by 492 · see citing works

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 461 · see citing works

Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology

Patrono, C. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.10.013 · Cited by 408 · see citing works

The Biological Relevance of Direct Antioxidant Effects of Polyphenols for Cardiovascular Health in Humans Is Not Established1–4

Hollman, P. C. H., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., Serafini, M., Scalbert, A., Sies, H., & Vidry, S. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.131490 · Cited by 406 · see citing works

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G., & Aepfelbacher, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6931 · Cited by 405 · see citing works

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · see citing works

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Macphee, C. H., Moores, K., Boyd, H., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., et al. (1999) · Biochemical Journal · doi:10.1042/bj3380479 · Cited by 359 · see citing works

Greater Oxidative Stress in Healthy Young Men Compared With Premenopausal Women

Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H., & Takeshita, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.104515 · Cited by 356 · see citing works

Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study—a randomized controlled trial

Mastroiacovo, D., Kwik-Uribe, C. L., Grassi, D., Necozione, S., Raffaele, A., Pistacchio, L., Righetti, R., Bocale, R., Lechiara, M. C., Marini, C., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092189 · Cited by 344 · see citing works

Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study

Desideri, G., Kwik-Uribe, C., Grassi, D., Necozione, S., Ghiadoni, L., Mastroiacovo, D., Raffaele, A., Ferri, L., Bocale, R., Lechiara, M. C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193060 · Cited by 311 · see citing works

Aspirin resistance: definition, mechanisms and clinical read-outs

Patrono, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00284.x · Cited by 298 · see citing works

Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects

Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T., & Zilmer, M. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003896 · Cited by 295 · see citing works

Supplementation With Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein: A Potential Link to Fatty Acid-Induced Insulin Resistance

Risérus, U., Basu, S., Jovinge, S., Fredrikson, G. N., Ärnlöv, J., & Vessby, B. (2002) · Circulation · doi:10.1161/01.cir.0000033589.15413.48 · Cited by 292 · see citing works

Human health implications of environmental contaminants in Arctic Canada: A review

Oostdam, J. V., Donaldson, S. G., Feeley, M., Arnold, D., Ayotte, P., Bondy, G. S., Chan, H. M., Dewailly, É., Furgal, C. M., Kuhnlein, H. V., et al. (2005) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2005.03.034 · Cited by 271 · see citing works

Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia

Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D. J., Kapoor, S. C., Rokach, J., Lawson, J. A., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.25.2822 · Cited by 271 · see citing works

8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases

Montuschi, P., TONI, G. C., Paredi, P., Pantelidis, P., du Bois, R. M., Kharitonov, S. A., & Barnes, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9803102 · Cited by 267 · see citing works

Uric acid reduces exercise-induced oxidative stress in healthy adults

Waring, W. S., CONVERY, A., Mishra, V., Shenkin, A., Webb, D. J., & Maxwell, S. R. J. (2003) · Clinical Science · doi:10.1042/cs20030149 · Cited by 257 · see citing works

Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F2 α-III, an Index of Oxidant Stress

Praticò, D., Basili, S., Vieri, M., Cordova, C., Violi, F., & FitzGerald, G. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9709066 · Cited by 254 · see citing works

Alcohol-induced generation of lipid peroxidation products in humans

Meagher, E. A., Barry, Ó. P., Burke, A., Lucey, M. R., Lawson, J. A., Rokach, J., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5584 · Cited by 251 · see citing works

Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men

Risérus, U., Vessby, B. O., Ärnlöv, J., & Basu, S. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.279 · Cited by 243 · see citing works

Bioavailability of lutein from vegetables is 5 times higher than that of β-carotene

Hof, K. H. V. H., Brouwer, I. A., West, C. E., Haddeman, E., Steegers‐Theunissen, R. P. M., van Dusseldorp, M., Weststrate, J. A., Eskes, T. K. A. B., & HAUTVAST, J. G. A. J. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.70.2.261 · Cited by 243 · see citing works

The Thromboxane Receptor Antagonist S18886 but Not Aspirin Inhibits Atherogenesis in Apo E–Deficient Mice

Cayatte, A. J., Du, Y., Oliver-Krasinski, J. M., Lavielle, G., Verbeuren, T. J., & Cohen, R. A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1724 · Cited by 237 · see citing works

Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors

Roberts, C. K., Won, D., Pruthi, S., Kurtovic, S., Sindhu, R. K., Vaziri, N. D., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01292.2005 · Cited by 232 · see citing works

Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina

Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Gregorio, D. D., Bucciarelli, T., Davı̀, G., Cuccurullo, F., & Patrono, C. (2000) · Circulation · doi:10.1161/01.cir.102.9.1007 · Cited by 225 · see citing works

Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target

Pascale, S., Petrucci, G., Dragani, A., Habib, A., Zaccardi, F., Pagliaccia, F., Pocaterra, D., Ragazzoni∘, E., Rolandi, G., Rocca, B., et al. (2012) · Blood · doi:10.1182/blood-2011-06-359224 · Cited by 219 · see citing works

IPF 2α -I: An index of lipid peroxidation in humans

Praticò, D., Barry, Ó. P., Lawson, J. A., Adiyaman, M., Hwang, S., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219 · see citing works

An Improved Method for the Measurement of Urinary and Plasma F2-Isoprostanes Using Gas Chromatography–Mass Spectrometry

Mori, T. A., Croft, K. D., Puddey, I. B., & Beilin, L. J. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.3037 · Cited by 214 · see citing works

Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake

Sandu, O. A., Song, K., Cai, W., Zheng, F., Uribarri, J., & Vlassara, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2314 · Cited by 213 · see citing works

Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease

Minuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R., Seta, F., Capone, M. L., Tacconelli, S., Palatresi, S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039528.49161.e9 · Cited by 211 · see citing works

Beyond Prostaglandins—Chemistry and Biology of Cyclic Oxygenated Metabolites Formed by Free‐Radical Pathways from Polyunsaturated Fatty Acids

Jahn, U., Galano, J., & Durand, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705122 · Cited by 206 · see citing works

Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels

Voutilainen, S., Morrow, J. D., Roberts, L. J., Alfthan, G., Alho, H., Nyyssönen, K., & Salonen, J. T. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1263 · Cited by 205 · see citing works

Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine

Pignatelli, P., Ghiselli, A., Buchetti, B., Carnevale, R., Natella, F., Germanò, G., Fimognari, F., Santo, S. D., Lenti, L., & Violi, F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.025 · Cited by 201 · see citing works

Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients

Takebayashi, K., Suetsugu, M., Wakabayashi, S., Aso, Y., & Inukai, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1249 · Cited by 198 · see citing works

Olive Phenol Hydroxytyrosol Prevents Passive Smoking–Induced Oxidative Stress

Visioli, F., Galli, C., Plasmati, E., Viappiani, S., Hernandez, A., Colombo, C., & Sala, A. (2000) · Circulation · doi:10.1161/01.cir.102.18.2169 · Cited by 192 · see citing works

Cardiovascular Responses to the Isoprostanes iPF2α-III and iPE2-III Are Mediated via the Thromboxane A2Receptor In Vivo

Audoly, L., Rocca, B., Fabre, J., Koller, B. H., Thomas, D. W., Loeb, A. L., Coffman, T. M., & FitzGerald, G. A. (2000) · Circulation · doi:10.1161/01.cir.101.24.2833 · Cited by 192 · see citing works

Plasma and Dietary Antioxidant Status as Cardiovascular Disease Risk Factors: A Review of Human Studies

Wang, Y., Chun, O. K., & Song, W. O. (2013) · Nutrients · doi:10.3390/nu5082969 · Cited by 191 · see citing works

The impact of moderate wine consumption on health

Artero, A., Artero, A., Tarín, J. J., & Cano, A. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.09.007 · Cited by 188 · see citing works

Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy

Ziegler, D., Sohr, C., & Nourooz‐Zadeh, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2178 · Cited by 182 · see citing works

Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study

Atteritano, M., Marini, H. R., Minutoli, L., Polito, F., Bitto, A., Altavilla, D., Mazzaferro, S., D’Anna, R., Cannata, M. L., Gaudio, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2295 · Cited by 176 · see citing works

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes

Bitar, M. S., Wahid, S., Mustafa, S., Al‐Saleh, E., Dhaunsi, G. S., & Al‐Mulla, F. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.014 · Cited by 174 · see citing works

Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet

Cambonie, G., Comte, B., Yzydorczyk, C., Ntimbane, T., Germain, N., Lê, N. L. O., Pladys, P., Gauthier, C., Lahaie, I., Abran, D., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00227.2006 · Cited by 171 · see citing works

Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry

Proudfoot, J. M., Barden, A. E., Mori, T. A., Burke, V., Croft, K. D., Beilin, L. J., & Puddey, I. B. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4187 · Cited by 175 · see citing works

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus

Takebayashi, K., Suetsugu, M., Wakabayashi, S., Aso, Y., & Inukai, T. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.001 · Cited by 174 · see citing works

Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data

Marchioli, R., Schweiger, C., Levantesi, G., Tavazzi, L., & Valagussa, F. (2001) · Lipids · doi:10.1007/s11745-001-0683-y · Cited by 173 · see citing works

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis

Mallat, Z., Nakamura, T., Ohan, J., Lesèche, G., Tedgui, A., Maclouf, J., & Murphy, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3985 · Cited by 172 · see citing works

Oxidized phospholipids and isoprostanes in atherosclerosis

Witztum, J. L., & Berliner, J. A. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00008 · Cited by 170 · see citing works

Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering

Wilson, S. H., Simari, R. D., Best, P. J. M., Peterson, T. E., Lerman, L. O., Aviram, M., Nath, K. A., Holmes, D. R., & Lerman, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.122 · Cited by 166 · see citing works

F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

Praticò, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00257-9 · Cited by 165 · see citing works

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F 2 -isoprostanes in human urine

Li, H., Lawson, J. A., Reilly, M. P., Adiyaman, M., Hwang, S., Rokach, J., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13381 · Cited by 161 · see citing works

Far-Infrared Therapy

Lin, C., Chang, C.-F., Lai, M.-Y., Chen, T.-W., Lee, P.-C., & Yang, W.-C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050534 · Cited by 161 · see citing works

Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease

Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 158 · see citing works

Oxidative stress and its association with coronary artery disease and different atherogenic risk factors

Vassalle, C., Petrozzi, L., Botto, N., Andreassi, M. G., & Zucchelli, G. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01373.x · Cited by 156 · see citing works

Protective activity of tomato products on in vivo markers of lipid oxidation

Visioli, F., Riso, P., Grande, S., Galli, C., & Porrini, M. (2003) · European Journal of Nutrition · doi:10.1007/s00394-003-0415-5 · Cited by 155 · see citing works

Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric Assay

Morrow, J. D., Zackert, W. E., Yang, J. P., Kurhts, E. H., Callewaert, D. M., Dworski, R., Kanai, K., Taber, D. F., Moore, K. P., Oates, J. A., et al. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4008 · Cited by 153 · see citing works

Heritability of Platelet Responsiveness to Aspirin in Activation Pathways Directly and Indirectly Related to Cyclooxygenase-1

Faraday, N. R., Yanek, L. R., Mathias, R. A., Herrera-Galeano, J. E., Vaidya, D. M., Moy, T. F., Fallin, M. D., Wilson, A. F., Bray, P. F., Becker, L. C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.667584 · Cited by 152 · see citing works

Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus

Davı̀, G., Chiarelli, F., Santilli, F., Pomilio, M., Vigneri, S., Falco, A., Basili, S., Ciabattoni, G., & Patrono, C. (2003) · Circulation · doi:10.1161/01.cir.0000074205.17807.d0 · Cited by 143 · see citing works

Oxidative stress in chronic vascular disease: From prediction to prevention

Santilli, F., D’Ardes, D., & Davı̀, G. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.003 · Cited by 140 · see citing works

Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples

DiMarco, T., & Giulivi, C. (2006) · Mass Spectrometry Reviews · doi:10.1002/mas.20109 · Cited by 140 · see citing works

Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall

Heinecke, J. W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1113 · Cited by 140 · see citing works

Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?

Wilund, K. R. (2007) · Clinical Science · doi:10.1042/cs20060368 · Cited by 138 · see citing works

Platelet dysfunction in central obesity

Anfossi, G., Russo, I., & Trovati, M. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.01.006 · Cited by 137 · see citing works

Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study

Sakata, R., Nakamura, T., Torimura, T., Ueno, T., & Sata, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1503 · Cited by 134 · see citing works

Hereditary Deficiency of gp91 phox Is Associated With Enhanced Arterial Dilatation

Violi, F., Sanguigni, V., Carnevale, R., Plebani, A., Rossi, P., Finocchi, A., Pignata, C., Mattia, D. D., Martire, B., Pietrogrande, M. C., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.877191 · Cited by 133 · see citing works

Oxidative Stress and Platelet Activation in Homozygous Homocystinuria

Davı̀, G., Minno, G. D., Coppola, A., Andria, G., Cerbone, A. M., Madonna, P., Tufano, A., Falco, A., Marchesani, P., Ciabattoni, G., et al. (2001) · Circulation · doi:10.1161/hc3501.095287 · Cited by 133 · see citing works

ANTIOXIDANT VITAMINS AND PREVENTION OF CARDIOVASCULAR DISEASE: LABORATORY, EPIDEMIOLOGICAL AND CLINICAL TRIAL DATA

Marchioli, R. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0480 · Cited by 130 · see citing works

Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus

Rehman, A., Nourooz‐Zadeh, J., Möller, W., Tritschler, H., Pereira, P., & Halliwell, B. B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00339-7 · Cited by 127 · see citing works

The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans

Ky, B., Burke, A., Tsimikas, S., Wolfe, M. L., Tadesse, M. G., Szapary, P. O., Witztum, J. L., FitzGerald, G. A., & Rader, D. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.026 · Cited by 124 · see citing works

BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction

Djamali, A., Sadowski, E. A., Muehrer, R. J., Reese, S. R., Smavatkul, C., Vidyasagar, A., Fain, S. B., Lipscomb, R. C., Hullett, D. H., Samaniego-Picota, M., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00222.2006 · Cited by 124 · see citing works

Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes

Mervaala, E. M. A., Cheng, Z. J., Tikkanen, I. T., Lapatto, R., Nurminen, K., Vapaatalo, H., Müller, D. N., Fiebeler, A., Ganten, U., Ganten, D., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.414 · Cited by 122 · see citing works

Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study

Jurt, U., Gori, T., Ravandi, A., Babaei, S., Zeman, P. R., & Parker, J. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01414-0 · Cited by 121 · see citing works

Platelets and diabetes mellitus

Santilli, F., Simeone, P., Liani, R., & Davı̀, G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.002 · Cited by 123 · see citing works

Inflammation and thrombosis in diabetes

Hess, K., & Grant, P. J. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0739 · Cited by 117 · see citing works

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury

Redecha, P. B., van Rooijen, N., Torry, D. S., & Girardi, G. (2009) · Blood · doi:10.1182/blood-2008-12-194258 · Cited by 117 · see citing works

Recent advances in the biochemistry and clinical relevance of the isoprostane pathway

Musiek, E. S., Yin, H., Milne, G. L., & Morrow, J. D. (2005) · Lipids · doi:10.1007/s11745-005-1460-7 · Cited by 117 · see citing works

Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease

Vassalle, C., Botto, N., Andreassi, M. G., Berti, S. L., & Biagini, A. (2003) · Coronary Artery Disease · doi:10.1097/01.mca.0000063504.13456.c3 · Cited by 117 · see citing works

Divergence between LDL Oxidative Susceptibility and Urinary F2-Isoprostanes as Measures of Oxidative Stress in Type 2 Diabetes

Devaraj, S., Hirany, S. V., Burk, R. F., & Jialal, I. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.11.1974 · Cited by 116 · see citing works

Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke

Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2012) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 115 · see citing works

Low density lipoprotein oxidation, antioxidants, and atherosclerosis

Catapano, A. L., Maggi, F. M., & Tragni, E. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200009000-00008 · Cited by 113 · see citing works

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

Iuliano, L., Praticò, D., Greco, C., Mangieri, E., Scibilia, G., FitzGerald, G. A., & Violi, F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01040-8 · Cited by 112 · see citing works

Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E

Tangirala, R. K., Praticò, D., FitzGerald, G. A., Chun, S. H., Tsukamoto, K., Maugeais, C., Usher, D. C., Puré, E., & Rader, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003324200 · Cited by 112 · see citing works

Aldosterone Blockade Attenuates Urinary Monocyte Chemoattractant Protein-1 and Oxidative Stress in Patients with Type 2 Diabetes Complicated by Diabetic Nephropathy

Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110 · see citing works

Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes

Abraham, N. G., Rezzani, R., Rodella, L. F., Kruger, A. L., Taller, D., Volti, G. L., Goodman, A. I., & Kappas, A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01187.2003 · Cited by 109 · see citing works

Effects of Vitamin E Supplementation on F2-Isoprostane and Thromboxane Biosynthesis in Healthy Cigarette Smokers

Patrignani, P., Panara, M. R., Tacconelli, S., Seta, F., Bucciarelli, T., Ciabattoni, G., Alessandrini, P., Mezzetti, A., Santini, G., Sciulli, M. G., et al. (2000) · Circulation · doi:10.1161/01.cir.102.5.539 · Cited by 108 · see citing works

F2-isoprostane formation, measurement and interpretation: The role of exercise

Nikolaidis, M. G., Kyparos, A., & Vrabas, I. S. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.002 · Cited by 106 · see citing works

Quantification of 8-iso-prostaglandin-F2α and 2,3-dinor-8-iso-prostaglandin-F2α in human urine using liquid chromatography-tandem mass spectrometry

Liang, Y., Wei, P., Duke, R. W., Reaven, P. D., Harman, S. M., Cutler, R. G., & Heward, C. B. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01018-3 · Cited by 105 · see citing works

F2-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes

Montero, A., Munger, K. A., Khan, R. Z., Valdivielso, J. M., Morrow, J. D., Guasch, A., Ziyadeh, F. N., & Badr, K. F. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00368.x · Cited by 103 · see citing works

Oxidative stress and diabetes mellitus

Kuyvenhoven, J. P., & Meinders, A. E. (1999) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(99)00009-6 · Cited by 103 · see citing works

Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms

Böger, R. H., Bode‐Böger, S. M., Phivthong‐ngam, L., Brandes, R. P., Schwedhelm, E., Mügge, A., Böhme, M., Tsikas, D., & Frölich, J. C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00145-2 · Cited by 103 · see citing works

Lipid peroxidation, isoprostanes and vascular damage.

Minuz, P., Fava, C., & Lechi, A. (2006) · PubMed · Cited by 53 · see citing works

Polish Academy ofSciences Review

Peroxidation, L., Minuz, P., Fava, C., & Lechi, R. (2013)

F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

Praticò, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00257-9 · Cited by 165 · see citing works

Isoprostanes and other markers of peroxidation in atherosclerosis

Patrignani, P., & Tacconelli, S. (2005) · Biomarkers · doi:10.1080/13547500500215084 · Cited by 47 · see citing works

THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO†

Morrow, J. D. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102340 · Cited by 187 · see citing works